With only 5% of US medical practices covered by data management systems, and a mandated requirement for all to be so by the end of 2018, PME is well placed to increase revenue, profit and margins.
There has been a hiatus in sales over the last year due to the Trump factor, but there will likely be a catch up period over the next year.
I've spoken to people in management over the last couple of years; PME have 15 - 20 bids in process and have only lost two. Their strike rate is phenomenal.
Mayo is still in the process of being implemented, and will be a giant reference point for marketing.
And let's nit forget that the contracted values are minimums. Typical clients sign up for 80% of existing use, so contract over performance is likely in every case....
PME Price at posting:
$5.15 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)